Octagon Launches Newest Version of StartingPoint®

Octagon Launches Newest Version of StartingPoint®

Leading Document Authoring Suite Expands to Over 275 Content Templates; New Functionality Further Supports Deployment of Global Submission Document Standards

DIA 2012

WAYNE, Pa.--Octagon Research Solutions, Inc. today announced the latest release of StartingPoint®, its industry-leading global submission document authoring solution, which it will be spotlighting at the upcoming 2012 DIA Annual Meeting in Philadelphia. With an expanded range of content templates and new capabilities supporting document creation and validation, the latest version of StartingPoint adds greater speed and efficiency to the authoring, review and publishing of submission documents.

StartingPoint enables the implementation of authoring standards across the functional areas involved in the development of regulatory submission documents. With StartingPoint, life science companies can leverage authoring standards to create high quality, consistently formatted source documents early in the submission lifecycle, minimizing rework and optimizing time-critical regulatory processes.

The StartingPoint suite now includes over 275 individual content templates each relating to a specific component of the CTD (common technical document) framework and supporting both U.S. and European regulatory submissions. Templates include instructional text from the International Conference on Harmonization (ICH) guidance documents, as well as automation of high value authoring functions.

Octagon's StartingPoint solution provides predefined heading styles, fonts, margins and table formats to ensure a consistent look and feel across all submission documents. New features include the addition of toolbars for PK symbols and non-numbered headings, and a button to switch between print layout and normal/draft views.

Expanded document validation functionality has also been incorporated into the latest StartingPoint release, including new checks for empty paragraphs and headings, incorrect headings, broken links, and floating figures. All enhancements are reflected in the revised version of the StartingPoint User Manual.

The latest release of StartingPoint is being rolled out at a time when life science companies are confronting increased challenges throughout their enterprise document management operations. In its recent document management survey of nearly 500 industry professionals, including over 100 respondents from the top 50 global pharmaceutical companies, Octagon found that 42% reported difficulty establishing standard naming conventions for clinical and regulatory documents throughout their organization.

Related concerns were also expressed in the area of author review and approval, with nearly half of the survey respondents (45%) indicating it is difficult for their organization, and another 11% stating it is very difficult. The press release highlighting the top-level survey results can be found here.

"Authoring standards are a critical foundation to the development of compliant and precise regulatory submission documents," said Kirk Gallion, President, Octagon Research Solutions, Inc. "Octagon has harnessed our deep submission expertise and technical knowledge to offer StartingPoint, enabling life science companies to rapidly deploy comprehensive document standards, saving them time and resources and helping keep pace with industry change. Teaming StartingPoint with our Quantum RIM™ (Regulatory Information Management) platform, Octagon delivers the pioneering technology solutions that optimize the entire submission development lifecycle."

For members of industry or media who wish to schedule a StartingPoint demo, booth #3225, at the DIA Annual Meeting, or to view Octagon's other solutions including Quantum RIM™ (Regulatory Information Management) or Quantum MDR™ (Metadata Registry), visit www.OctagonResearch.com/2012DIA.

About Octagon Research Solutions, Inc.

Octagon is the world leader in clinical and regulatory information management solutions to the life sciences industry. Through an integrated suite of outsourced services, strategic consulting, and innovative technology, Octagon optimizes the entire drug development lifecycle – from clinical data collection to regulatory submission. Founded in 1999, Octagon has served over 350 clients on three continents, including global pharmaceutical brand leaders and emerging start-ups. The company is headquartered in Wayne, PA, and maintains additional U.S. and international operations in Mountain View, CA, London, United Kingdom, and Bangalore, India.

For additional information, visit www.octagonresearch.com.

Contacts

Octagon Research Solutions, Inc.
Ellen Semple
Senior Director, Global Marketing
o. 610-535-6500 x. 5507
m. 484-431-7546
[email protected]
 

Suggested Articles

Werewolf is launching with $56 million and an approach that can cut through the toxic effects that have limited certain cancer-killing agents.

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.